ArticleResearch square2025
Differences in lung cancer screening outcomes and follow-up by patient, provider and place-based characteristics in Missouri and Illinois: A cross-sectional study.
Article in Research square, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Background: Lung cancer remains the leading cause of cancer-related mortality in the United States, yet disparities in lung cancer screening (LCS) outcomes exist and remain understudied, particularly in the Midwestern region. Our objective was to investigate disparities in lung radiology outcomes and follow-up care based on patient, provider, and place-based characteristics (i.e., area deprivation index; ADI). Methods: This cross-sectional study used data from the LCS program at Siteman Cancer Center (SCC) in St. Louis, Missouri, from January to December 2023. SCC's catchment area includes 82 counties in Missouri and Illinois; approximately 15% of the population reside in a rural zip code, and 29% reside in medically underserved areas 80% are White. The study included 1,946 individuals aged 50-80, meeting LCS eligibility criteria based on smoking history and age. Lung radiology findings were assessed as primary outcomes, and timely follow-up adherence (i.e., return for follow-up visit) was analyzed among patients with high-risk findings (Lung-RADS 3 ["Probably Benign"] and 4 ["Suspicious"]) from January to June 2023, requiring follow-up by December 2023. Multivariable logistic regression was conducted, adjusting for patient and provider characteristics and ADI. Results: Of the 1,946 individuals who accessed LCS, 57% were Black, 41% White, 1% Asian, and 1% of another race; 54% were male and 46% female. Lung findings were classified as "probably benign/suspicious" (high risk) for 14%. Annual visits were associated with higher likelihood of high-risk scores compared to baseline visits (AOR = 2.10 (1.40-3.15); p < 0.001). Racial differences were noted in the association between provider type and lung outcomes. Among White individuals only, specialist compared to primary care provider referral was associated with increased odds of being high risk (AOR = 1.58 (1.00-2.50); p = 0.048). Sex, insurance, smoking status, park-years and ADI were not associated with lung radiology outcomes. Timely adherence to return follow-up visit among high-risk patients was suboptimal, with only 20.0% returning within 3-6 months for their repeat LCS. Individuals residing in moderate ADI (distress) areas were less likely to have timely follow-up (for high-risk findings) compared to those in high distress (AOR = 0.393, 95% CI = 0.155-1.001, p = 0.050). There were no differences by sex, insurance, smoking status, and pack-years for being classified as high risk. Conclusions: SCC's LCS program successfully captured Black populations and individuals from highly distressed areas, in a predominantly White catchment area. There were no observable race disparities in timely follow-up of high-risk findings, reflecting progress toward equity in access and outcomes. Place-based disparities in follow-up were observed that warrant further characterization and risk assessment to improve follow-up of patients undergoing LCS.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.